AMRX
Price:
$8.39
Market Cap:
$2.60B
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, p...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-05-07
Stock Exchange
NYSE
Ticker
AMRX
According to Amneal Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -10.62. This represents a change of -146.81% compared to the average of 22.69 of the last 4 quarters.
The mean historical PE Ratio of Amneal Pharmaceuticals, Inc. over the last ten years is 8.65. The current -10.62 PE Ratio has changed -12374.06% with respect to the historical average. Over the past ten years (40 quarters), AMRX's PE Ratio was at its highest in in the September 2018 quarter at 98.34. The PE Ratio was at its lowest in in the December 2020 quarter at -55.54.
Average
8.65
Median
3.67
Minimum
-12.73
Maximum
47.69
Discovering the peaks and valleys of Amneal Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual PE Ratio = 47.69
Minimum Annual Increase = -1031.49%
Minimum Annual PE Ratio = -12.73
Year | PE Ratio | Change |
---|---|---|
2023 | -12.73 | 979.71% |
2022 | -1.18 | -103.33% |
2021 | 35.37 | 259.94% |
2020 | 9.83 | -1031.49% |
2019 | -1.05 | -89.60% |
2018 | -10.14 | -188.93% |
2017 | 11.41 | 55.44% |
2016 | 7.34 | -84.61% |
2015 | 47.69 | Infinity% |
The current PE Ratio of Amneal Pharmaceuticals, Inc. (AMRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.15
5-year avg
6.05
10-year avg
8.65
Amneal Pharmaceuticals, Inc.’s PE Ratio is less than Alkermes plc (15.66), less than Neurocrine Biosciences, Inc. (35.71), greater than Intra-Cellular Therapies, Inc. (-90.48), greater than Deciphera Pharmaceuticals, Inc. (-11.74), less than Dynavax Technologies Corporation (84.07), less than Amphastar Pharmaceuticals, Inc. (13.33), less than Collegium Pharmaceutical, Inc. (12.07), less than Ironwood Pharmaceuticals, Inc. (77.85), less than ANI Pharmaceuticals, Inc. (43.28), less than Phibro Animal Health Corporation (324.20), less than Procaps Group S.A. (4.69), less than Silver Spike Investment Corp. (14.29), less than Eagle Pharmaceuticals, Inc. (5.10), greater than Evolus, Inc. (-17.34), less than Agile Therapeutics, Inc. (-0.65), less than Assertio Holdings, Inc. (-0.35), less than AcelRx Pharmaceuticals, Inc. (-1.83), less than Lifecore Biomedical, Inc. (12.14),
Company | PE Ratio | Market cap |
---|---|---|
15.66 | $4.42B | |
35.71 | $12.13B | |
-90.48 | $7.77B | |
-11.74 | $2.21B | |
84.07 | $1.45B | |
13.33 | $2.21B | |
12.07 | $1.20B | |
77.85 | $720.42M | |
43.28 | $1.27B | |
324.20 | $788.20M | |
4.69 | $218.91M | |
14.29 | $71.22M | |
5.10 | $55.19M | |
-17.34 | $928.12M | |
-0.65 | $10.43M | |
-0.35 | $120.12M | |
-1.83 | $14.58M | |
12.14 | $147.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amneal Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amneal Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Amneal Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the highest PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the 3-year average PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX)?
What is the 5-year average PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX)?
How does the current PE Ratio for Amneal Pharmaceuticals, Inc. (AMRX) compare to its historical average?